IL10 and lung cancer: Parallel observations from Chinese lung cancer cohorts included enriched TNF-α pathway activity and higher plasma TNF levels [89], while elevated IL-10/CCL2 in elderly patients and ST6GAL1 in high-grade irAEs further highlight shared inflammatory axes [90].